Jun 21, 2021 / 06:00PM GMT
Dane Leone - Raymond James Financial, Inc. - Analyst
Hi, everyone. Welcome back to the next session here at the Raymond James Human Health Innovation Conference virtual format 2021. My name is Dane Leone; I'm one of the senior biotech analysts on the Ray J team. With me for this session, we will have a fireside chat with the management team of Cytokinetics. I'm extremely pleased to have the CEO, Robert Blum with me, and Fady Malik. It's going to be a great discussion today, do some Q&A.
Before we jump into some of the questions though, I want to hand it over to Robert and Fady to give a brief introduction of themselves. So, Robert, do you want to jump in first -- or, Fady, do you want to start?
Fady Malik - Cytokinetics, Incorporated - EVP, R&D
I'll start first, Dane. Hi, everybody. I'm Fady Malik; I'm the Head of R&D at Cytokinetics, helped launch the Company back in 1998, and I'm a physician-scientist of cardiology background.
Robert Blum - Cytokinetics, Incorporated - President & CEO
Good
Cytokinetics Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot